| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-04-30 FY | 2021-04-30 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $6.59M | $3.42M | $3.60M | – | – |
| R&D | – | $0.00 | $664.01K | – | – |
| SG&A | $532.70K | $724.02K | $810.07K | $55.99K | $41.56K |
| Operating Income | -$6.59M | -$3.42M | -$3.60M | -$55.99K | -$41.56K |
| Interest Expense | $47.41K | $92.19K | $60.75K | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.41M | -$2.82M | -$3.68M | -$55.99K | -$41.56K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | -0.0300 | 0.0000 | -0.0200 | – | – |
| Shares (diluted) | $219.49M | $206.70M | $202.75M | – | – |